Dental Pulp Stem Cell Supernatant for Multifactorial Cancer Cachexia
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for cancer cachexia, such as those using anamorelin, megestrol acetate, melatonin, and ostarine, are inadequate, and existing compositions containing extracellular vesicles from mesenchymal stem cells do not effectively address cachexia symptoms.
Innovation Solution
A culture supernatant derived from dental pulp-derived stem cells, containing microparticles such as exosomes, is administered to improve cancer cachexia symptoms by suppressing blood cytokines and enhancing hemocyte levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional treatments (anamorelin, megestrol acetate, melatonin, ostarine) are used for cancer cachexia, then some symptomatic relief may be achieved, but the treatments are inadequate and do not effectively address the multifactorial nature of cachexia including weight loss, undernutrition, and anemia
Solution Approach 1:
The culture supernatant of dental pulp-derived stem cells serves multiple functions simultaneously: it suppresses inflammatory cytokines (IL-6, TNF-α), improves nutritional status, corrects anemia by enhancing hemocyte levels, and reduces weight loss. This multi-functional approach addresses the multifactorial nature of cancer cachexia that conventional single-target treatments fail to resolve effectively.
2Reliability
If extracellular vesicles from mesenchymal stem cells are administered, then some therapeutic effect is intended, but existing compositions do not effectively improve cachexia symptoms
Solution Approach 1:
The invention changes the source parameter of the extracellular vesicles from conventional mesenchymal stem cells to dental pulp-derived stem cells. This parameter change results in culture supernatant with enhanced therapeutic properties, specifically superior cytokine suppression capability and hemocyte enhancement effect, thereby effectively improving cachexia symptoms where previous compositions failed.
3Reliability
If cytokine levels are suppressed to improve cachexia, then weight loss and undernutrition may be reduced, but the mechanism must be specific enough to avoid suppressing beneficial immune functions
Solution Approach 1:
The culture supernatant of dental pulp-derived stem cells acts as an intermediary substance that mediates the suppression of harmful cytokines (IL-6, TNF-α) without directly inhibiting immune cell function. The supernatant contains bioactive factors that selectively modulate the cytokine environment, reducing the harmful inflammatory response while preserving beneficial immune surveillance and anti-tumor immunity.
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
An agent for improving cancer cachexia used for administration to a subject with cancer cachexia which is a composition containing a culture supernatant of dental pulp-derived stem cells and in which the culture supernatant contains microparticles derived from the dental pulp-derived stem cells is a novel agent for improving cancer cachexia; a method for improving cancer cachexia.